A
ACADIA Pharmaceuticals Inc.
ACAD · NASDAQ · Healthcare · 4.8B
Closing price
$19.78
+1.02% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
8.6×
Price / net assetsP/B
2.7×
Enterprise value / EBITDAEV/EBITDA
21.4×
Free cash flow yieldFCF yield
3.1%
Return on equityROE
31.9%
Operating margin
9.8%
Net debt / EBITDAbalance-sheet strength
-0.8×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.